Home > Riviste > The Quarterly Journal of Nuclear Medicine and Molecular Imaging

ULTIMO FASCICOLOTHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Rivista di Medicina Nucleare e Imaging Molecolare


A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413


Periodicità: Trimestrale

ISSN 1824-4785

Online ISSN 1827-1936


eTOC

Gli articoli più letti nelle ultime tre settimane

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):135-44
European regulations for the introduction of novel radiopharmaceuticals in the clinical setting
Clemens DECRISTOFORO *, Ivan PENUELAS, Marianne PATT, Sergio TODDE

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):153-67
Radiolabeled peptides: current and new perspectives
Marta OPALINSKA *, Alicja HUBALEWSKA-DYDEJCZYK, Anna SOWA-STASZCZAK

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):168-80
Radiolabeled prostate-specific membrane antigen small-molecule inhibitors
Leon WILL, Ida SONNI, Klaus KOPKA, Clemens KRATOCHWIL, Frederik L. GIESEL *, Uwe HABERKORN

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):145-52
Preclinical in vivo cancer, straightway to patients?
Marion de JONG *, Stephen MATHER, Theodosia MAINA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):181-204
Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview
Rubel CHAKRAVARTY *, Shreya GOEL, Ashutosh DASH, Weibo CAI

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):133-4
New tracers to the clinic
Marion de JONG *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):205-15
Staging of locally advanced breast cancer and the prediction of response to neoadjuvant chemotherapy: complementary role of scintimammography and 18F-FDG PET/CT
Laura EVANGELISTA *, Anna R. CERVINO, Silvia MICHIELETTO, Tania SAIBENE, Enrico ORVIETO, Fernando BOZZA, Cristina GHIOTTO

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 June;61(2):216-31
Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerations
Anna SARNELLI *, Francesco GUERRIERO, Francesca BOTTA, Mahila FERRARI, Lidia STRIGARI, Lisa BODEI, Vincenzo D’ERRICO, Elisa GRASSI, Federica FIORONI, Giovanni PAGANELLI, Roberto ORECCHIA, Marta CREMONESI

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2008 September;52(3):245-53
In vitro receptor binding assays: general methods and consideration
Bigott-Hennkens H. M., Dannoon S., Lewis M. R., Jurisson S. S.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2017 March;61(1):19-32
Advances in multimodal molecular imaging
Luigi AULETTA, Matteo GRAMANZINI, Sara GARGIULO, Sandra ALBANESE, Marco SALVATORE, Adelaide GRECO *

inizio pagina